Cipla's subsidiary InvaGen's manufacturing plant has received five inspectional observations in Form 483 from USFDA.
from Economic Times https://ift.tt/xhRFGQZ
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment